This website is intended for healthcare professionals only

Search Results

13 Results Found for “aortic valve calcification”

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Coverage from: EuroPCR Highlights

New late-breaking data presented on Day 3 of EuroPCR 2026 highlighted evolving approaches to antiplatelet therapy, transcatheter treatment of pure aortic regurgitation and procedural optimization in bicuspid TAVR

Heart Human Anatomy Details Generative AI
Mark CompleteCompleted
BookmarkBookmarked

The Evolut Low Risk trial (Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement; ClinicalTrials.gov identifier: NCT02701283) provides reassuring evidence that transcatheter aortic valve replacement (TAVR) ...

May 2025 Cardiology Roundup: Latest Approvals and Therapeutic Updates
Mark CompleteCompleted
BookmarkBookmarked

May 2025 saw several significant developments in the field of cardiology, including new regulatory approvals, long-term clinical trial data and important findings from late-breaking studies. This roundup highlights the latest updates across structural, interventional and heart failure therapies, with implications for ...

Mark CompleteCompleted
BookmarkBookmarked

Over the past two decades, the field of transcatheter aortic valve replacement (TAVR) has experienced remarkable advancement. Initially approved for patients with high and prohibitive surgical risk, TAVR has progressively extended its indications to all patients, regardless of surgical risk. ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest issue of Heart International. This edition includes a range of articles on topics showcasing the latest advances in our understanding and treatment of cardiovascular disease. We begin with focus on the hereditary cardiac disorder, hypertrophic cardiomyopathy, ...

Mark CompleteCompleted
BookmarkBookmarked

Mitral valve (MV) disease includes either mitral regurgitation or mitral stenosis or both. The incidence and prevalence of valvular heart disease is increasing with the increasing population age. Degenerative MV disease poses a global burden with a prevalence of 18.1 million ...

Mark CompleteCompleted
BookmarkBookmarked
Nishant Sharma, Ayaaz K Sachedina, Sachin Kumar

The global prevalence of aortic stenosis (AS) has steadily increased over the past several decades.1 In high-income countries, degenerative calcific aortic valve disease is the primary aetiology for AS, whereas chronic rheumatic valve disease and infective endocarditis remain more common ...

Mark CompleteCompleted
BookmarkBookmarked

In recent years, patients undergoing non-emergent percutaneous coronary intervention (PCI) procedures have become increasingly older, with a more significant comorbidity burden and complex coronary disease.1 Many of the patients who undergo elective or urgent PCI are surgical turndown patients, for ...

Heart within chest digital image
Mark CompleteCompleted
BookmarkBookmarked
Tomoya T Hinohara, Michael J Reardon, Sachin S Goel

Transcatheter-based therapies have become central to the treatment of valvular heart disease, particularly aortic stenosis.1–5 The first transcatheter aortic valve replacement (TAVR) was performed in 2002 and, in two short decades, TAVR has become a mainstay for the treatment of aortic ...

Mark CompleteCompleted
BookmarkBookmarked

Transcatheter aortic valve replacement (TAVR) has seen worldwide explosive growth. The current USA guidelines no longer use risk in choosing between TAVR and surgical aortic valve replacement, and the European guidelines have extended the recommendation for TAVR to lower risk ...

Mark CompleteCompleted
BookmarkBookmarked

Aortic stenosis is a common degenerative valve disease and its prevalence increases with age.1 If untreated, severe symptomatic aortic stenosis leads to significant morbidity and mortality.2 Although surgical aortic valve replacement (SAVR) is a well-established treatment option for this condition, ...

Mark CompleteCompleted
BookmarkBookmarked

Perioperative management of a mediastinal tumour is an anaesthetic challenge. Echocardiography is not considered as a primary diagnostic modality in the evaluation of a mediastinal mass; however, it can provide valuable information in patients with clinical and diagnostic evidence of ...

Mark CompleteCompleted
BookmarkBookmarked
Deep Chandh Raja, Vickram Vignesh Rangaswamy, Sreevilasam Pushpangadhan Abhilash

Premature ventricular complexes (PVCs) can cause significant left ventricular (LV) dysfunction leading to debilitating symptoms.1 Multiple single-centre studies have shown that the catheter ablation is effective in curing these PVCs.2,3 However, catheter ablation of ventricular arrhythmias (VAs) originating from papillary ...

Load More...
Close Popup